tecentriq-hcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * SITEMAP: https://www.tecentriq-hcp.com/sitemap.xml | ||
Meta Tags
| Title | TECENTRIQ® (atezolizumab) HCP | Efficacy, Safety, PI & |
| Description | 53,000+ US PATIENTS Information for healthcare professionals about the safety, efficacy, dosing, prescribing information and mechanism of action for TECENTRIQ® (atezolizumab). See full safety for additional |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.18.31.61 |
| Location | Singapore |
Related Websites
| Site | Rank |
More to Explore
tecentriq-hcp.com Valuation
|
US$9,235,593
Last updated: 2022-06-24 06:28:53
tecentriq-hcp.com has Semrush global rank of 1,146,034. tecentriq-hcp.com has an estimated worth of US$ 9,235,593, based on its estimated Ads revenue. tecentriq-hcp.com receives approximately 1,065,646 unique visitors each day. Its web server is located in Singapore, with IP address 104.18.31.61. According to SiteAdvisor, tecentriq-hcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,235,593 |
| Daily Ads Revenue | US$8,526 |
| Monthly Ads Revenue | US$255,755 |
| Yearly Ads Revenue | US$3,069,059 |
| Daily Unique Visitors | 71,044 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tecentriq-hcp.com. | A | 300 | IP: 104.18.31.61 |
| tecentriq-hcp.com. | A | 300 | IP: 104.18.30.61 |
| tecentriq-hcp.com. | AAAA | 300 | IPV6: 2606:4700::6812:1f3d |
| tecentriq-hcp.com. | AAAA | 300 | IPV6: 2606:4700::6812:1e3d |
| tecentriq-hcp.com. | NS | 86400 | NS Record: lara.ns.cloudflare.com. |
| tecentriq-hcp.com. | NS | 86400 | NS Record: alan.ns.cloudflare.com. |
| tecentriq-hcp.com. | TXT | 300 | TXT Record: 25pls67yxtyg76lvrvbrl0ztpd1cv1dn |
| tecentriq-hcp.com. | TXT | 300 | TXT Record: v=spf1 -all |
HtmlToTextCheckTime:2022-06-24 06:28:53
| Prescribing Information For Patients and Caregivers Prescribing Information Prescribing Information MENU For Patients and Caregivers Non-Small Cell Lung Cancer Extensive-Stage Small Cell Lung Cancer Unresectable or Metastatic Hepatocellular Carcinoma Unresectable or Metastatic Melanoma Locally Advanced or Metastatic Urothelial Carcinoma 53,000+ US PATIENTS TREATED * Non-Small Cell Lung Cancer Extensive-Stage Small Cell Lung Cancer Unresectable or Metastatic Hepatocellular Carcinoma Unresectable or Metastatic Melanoma Locally Advanced or Metastatic Urothelial Carcinoma *PBRER data ending November 2020 and internal forecast data for December 2020. The PBRER is based on milligrams of atezolizumab (TECENTRIQ) sold. PBRER=Periodic Benefit-Risk Evaluation Report. Important Safety Information Back to Top Indications Locally Advanced or Metastatic Urothelial Carcinoma TECENTRIQ is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma who: Are |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sun, 24 Oct 2021 17:01:41 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Sun, 24 Oct 2021 18:01:41 GMT Location: https://tecentriq-hcp.com/ Set-Cookie: __cfruid=204a15eeab40c005c36faae984bc6d13d035eb5a-1635094901; path=/; domain=.tecentriq-hcp.com; HttpOnly Server: cloudflare CF-RAY: 6a34c4bb2f948353-ORD HTTP/2 301 date: Sun, 24 Oct 2021 17:01:41 GMT content-type: text/html; charset=iso-8859-1 location: https://www.tecentriq-hcp.com/ cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=204a15eeab40c005c36faae984bc6d13d035eb5a-1635094901; path=/; domain=.tecentriq-hcp.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a34c4bb9d202aa5-ORD HTTP/2 200 date: Sun, 24 Oct 2021 17:01:41 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" set-cookie: __cfruid=204a15eeab40c005c36faae984bc6d13d035eb5a-1635094901; path=/; domain=.tecentriq-hcp.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 6a34c4bdbe5261c8-ORD |
tecentriq-hcp.com Whois Information
Domain Name: TECENTRIQ-HCP.COM Registry Domain ID: 2140400959_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2021-08-01T03:19:07Z Creation Date: 2017-07-06T08:12:09Z Registry Expiry Date: 2023-07-06T08:12:09Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ALAN.NS.CLOUDFLARE.COM Name Server: LARA.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T23:31:20Z <<< |